Kevin Schmidt

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Fraunhofer Institute for Toxicology and Experimental Medicine(Current)

Medizinische Hochschule Hannover

Kevin Schmidt is an author at Fraunhofer Institute for Toxicology and Experimental Medicine specializing in cardiac fibrosis modulation, molecular pharmacology, and mitochondrial respiration inhibition.

ORCID

Publications per year

2024–2024

Publications

SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation

Kevin Schmidt, Arne Schmidt, Sonja Groß et al. · Scientific Reports · 2024 · 20 citations · Full text

Medicine, Cardiology, Pharmacology +17

Single-nucleus RNA sequencing identifies cell-type–specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices

Kevin Schmidt, Maximilian Fuchs, Natalie Weber et al. · European Heart Journal · 2024 · 15 citations · Full text

Life Sciences, Pharmacology, Gene Expression +1

1–2 of 2